Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
701	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2023	Standard Therapy	Poland	47
702	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2023	Standard Therapy	Poland	38
703	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2023	Standard Therapy	Poland	71
704	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2023	Standard Therapy	Poland	50
705	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2023	Standard Therapy	Poland	67
706	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2023	Standard Therapy	Poland	66
707	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2023	Standard Therapy	Poland	65
708	Apheresis	Autologous	Anaplastic Lymphoma Kinase Positive Anaplastic Large-Cell Lymphoma	Hematology	2023	Standard Therapy	Germany	37
709	Apheresis	Allogeneic	Bare Lymphocyte Syndrome Type Ii	Hematology	2023	Standard Therapy	Poland	3 months
710	Apheresis	Allogeneic	B-Cell Acute Lymphoblastic Leukemia	Hematology	2023	Standard Therapy	Poland	66
711	Apheresis	Allogeneic	B-Cell Acute Lymphoblastic Leukemia	Hematology	2023	Standard Therapy	Poland	49
712	Apheresis	Autologous	B-Cell Lymphoma	Hematology	2023	Standard Therapy	Germany	66
713	Apheresis	Allogeneic	B-Cell Precursor Acute Lymphocytic Leukemia	Hematology	2023	Standard Therapy	Poland	53
714	Apheresis	Allogeneic	B-Cell Precursor Acute Lymphocytic Leukemia	Hematology	2023	Standard Therapy	Poland	27
715	Apheresis	Allogeneic	B-Cell Precursor Acute Lymphocytic Leukemia	Hematology	2023	Standard Therapy	Poland	51
716	Apheresis	Allogeneic	Beta Thalassemia Major	Hematology	2023	Standard Therapy	Poland	4
717	Apheresis	Allogeneic	Blastic Plasmacytoid Dendritic Cell Neoplasm	Hematology	2023	Standard Therapy	Poland	66
718	Apheresis	Allogeneic	Cell Neoplasm	Hematology	2023	Standard Therapy	Germany	47
719	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2023	Standard Therapy	Poland	61
720	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Poland	43
721	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Germany	36
722	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Poland	62
723	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Poland	59
724	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Poland	37
725	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Poland	41
726	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Poland	54
727	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Poland	61
728	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Poland	54
729	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2023	Standard Therapy	Germany	28
730	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2023	Standard Therapy	Poland	62
731	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2023	Standard Therapy	Poland	65
732	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2023	Standard Therapy	Poland	64
733	Apheresis	Autologous	Composite Lymphoma	Hematology	2023	Standard Therapy	Germany	71
734	Apheresis	Allogeneic	Congenital Pulmonary Lymphangiectasia	Hematology	2023	Standard Therapy	Poland	50
735	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2023	Standard Therapy	Germany	59
736	Apheresis	Allogeneic	Diffuse Large B-Cell Lymphoma	Hematology	2023	Standard Therapy	Poland	50
737	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2023	Standard Therapy	Germany	70
738	Apheresis	Allogeneic	Es	Hematology	2023	Standard Therapy	Poland	62
739	Apheresis	Autologous	Follicular Lymphoma	Hematology	2023	Standard Therapy	Germany	62
740	Apheresis	Allogeneic	Follicular Lymphoma	Hematology	2023	Standard Therapy	Poland	53
741	Apheresis	Allogeneic	Hemophagocytic Lymphohistiocytosis (Hlh)	Hematology	2023	Standard Therapy	Poland	4 months
742	Apheresis	Autologous	Hodgkin – Relapse	Hematology	2023	Standard Therapy	Germany	43
743	Apheresis	Allogeneic	Huntington's Disease (Hd)	Hematology	2023	Standard Therapy	Germany	36
744	Apheresis	Allogeneic	Hypoplastic Myelodysplastic Syndrome	Hematology	2023	Standard Therapy	Poland	27
745	Apheresis	Allogeneic	Immunodeficiency	Hematology	2023	Standard Therapy	Poland	4
746	Apheresis	Allogeneic	Inherited Immune System Disorder	Hematology	2023	Standard Therapy	Poland	16
747	Apheresis	Allogeneic	Langerhans Cell Sarcoma	Hematology	2023	Standard Therapy	Poland	66
748	Apheresis	Autologous	Light-Chain Amyloidosis	Hematology	2023	Standard Therapy	Germany	62
749	Apheresis	Allogeneic	Macrofocal Multiple Myeloma	Hematology	2023	Standard Therapy	Poland	94
750	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2023	Standard Therapy	Germany	54
751	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2023	Standard Therapy	Germany	64
752	Apheresis	Allogeneic	Mast Cell Sarcoma, Systemic Mastocytosis Nr	Hematology	2023	Standard Therapy	Poland	51
753	Apheresis	Allogeneic	Mixed Phenotype Acute Leukemia	Hematology	2023	Standard Therapy	Poland	64
754	Apheresis	Autologous	Morbus Hodgkin	Hematology	2023	Standard Therapy	Germany	43
755	Apheresis	Autologous	Morbus Hodgkin	Hematology	2023	Standard Therapy	Germany	57
756	Apheresis	Allogeneic	Mucopolysaccharidosis /Myelodysplastic Syndrome Overlap	Hematology	2023	Standard Therapy	Poland	71
757	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	47
758	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	53
759	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	65
760	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	60
761	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	63
762	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	63
763	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	72
764	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	61
765	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	68
766	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	54
767	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	67
768	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	69
769	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	61
770	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	63
771	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	63
772	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	61
773	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	64
774	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	69
775	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	58
776	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	56
777	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	66
778	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	63
779	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2023	Standard Therapy	Poland	56
780	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	53
781	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	66
782	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	59
783	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	59
784	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	64
785	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	63
786	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	68
787	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	60
788	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	42
789	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	62
790	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	50
791	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	59
792	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	56
793	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	64
794	Apheresis	Autologous	Multiple Myeloma	Hematology	2023	Standard Therapy	Germany	59
795	Apheresis	Allogeneic	Mycosis Fungoides	Hematology	2023	Standard Therapy	Poland	62
796	Apheresis	Allogeneic	Myelodysplastic Disorders	Hematology	2023	Standard Therapy	Poland	57
797	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2023	Standard Therapy	Poland	71
798	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2023	Standard Therapy	Poland	64
799	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2023	Standard Therapy	Poland	67
800	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2023	Standard Therapy	Poland	56

Previous

Page 8 of 72 1 6 7 8 9 10 72

Next